Washington DC – Analysts for recent research have designed pioneering techniques to distinguish between immune cells in tumors that could accelerate the development of cancer treatment.
Researchers at the University of Edinburgh have analyzed genes from anonymous medical databases of thousands of tumors to identify genes associated with immune cells. The findings of the study were published in the journal Cancer Research Immunology.
Scientists have said that access can be used to help doctors select the best treatments for individual patients and predict which tumors will likely respond to a particular therapy.
It could also help guide the use of immunotherapy – a new form of treatment that uses its own defense of the cancer control body. This therapy has shown great promise in the past few years, but identifying which patient will respond is the best challenge for doctors.
A new approach – based on gene analysis – makes it easier to identify the extent of immune cells present in the tumor. These cells can help the organism detect and kill cancer when it is activated by certain drugs, scientists say.
Traditional treatments, such as radiology, do not discriminate between cell types and attack both carcinogenic and healthy cells, often leading to adverse effects.
A source called ImSig – shows the best picture of the tumor so far and will allow scientists to study how certain types of immune cells affect cancer growth.